BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agrati C, Sacchi A, Tartaglia E, Vergori A, Gagliardini R, Scarabello A, Bibas M. The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review. Int J Mol Sci 2021;22:7942. [PMID: 34360707 DOI: 10.3390/ijms22157942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Quah Y, Lee YY, Lee SJ, Kim SD, Rhee MH, Park SC. In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism. J Ginseng Res 2022. [PMID: 36160270 DOI: 10.1016/j.jgr.2022.09.001] [Reference Citation Analysis]
2 Müller R, Rink G, Uzun G, Bakchoul T, Wuchter P, Klüter H, Bugert P. Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors. Thrombosis Research 2022;216:120-4. [DOI: 10.1016/j.thromres.2022.06.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Golubeva MG. Role of P-Selectin in the Development of Hemostasis Disorders in COVID-19. Biol Bull Rev 2022;12:406-413. [DOI: 10.1134/s207908642204003x] [Reference Citation Analysis]
4 Tarasev M, Mota S, Gao X, Ferranti M, Zaidi AU, Hannan B, Hines P. Possible Role of P-selectin Adhesion in Long-COVID: A Comparative Analysis of a Long-COVID Case Versus an Asymptomatic Post-COVID Case.. [DOI: 10.1101/2022.03.09.22271297] [Reference Citation Analysis]
5 Pluta K, Porębska K, Urbanowicz T, Gąsecka A, Olasińska-Wiśniewska A, Targoński R, Krasińska A, Filipiak KJ, Jemielity M, Krasiński Z. Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases. Biology (Basel) 2022;11:224. [PMID: 35205091 DOI: 10.3390/biology11020224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Romanov Y. SARS-CoV-2, COVID-19 and cardiovascular complications from the position of vascular endothelium. Kardio vestn 2022;17:21. [DOI: 10.17116/cardiobulletin20221701121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Leucker TM, Osburn WO, Reventun P, Smith K, Claggett B, Kirwan BA, de Brouwer S, Williams MS, Gerstenblith G, Hager DN, Streiff MB, Solomon SD, Lowenstein CJ. Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial. JACC Basic Transl Sci 2021;6:935-45. [PMID: 34904132 DOI: 10.1016/j.jacbts.2021.09.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]